Internal Medicine · Houston, TX
NPI
1649350901
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
12924 Bellaire Blvd, Ste 100
Houston, TX, 77072
Phone (713) 457-5500
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
534 services
Medicare patients, 2024
94
Average age 77
Drug cost, 2024
$3.2M
23,777 prescriptions
Company payments, 2025
$1,069
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tram Ho was code 99215 (office e&m - established), 145 times for 70 patients. In total Tram Ho billed 534 services in 25 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 145 | 70 | $114.58 | $17K |
| 99214 Office E&M - Established | Office | 91 | 52 | $78.66 | $7,158 |
| 99213 Office E&M - Established | Office | 67 | 49 | $57.61 | $3,860 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 49 | 49 | $129.91 | $6,365 |
| 93000 Electrocardiogram | Office | 39 | 39 | $8.21 | $320 |
| 90662 Vaccine Product | Office | 29 | 27 | $79.77 | $2,313 |
| G0008 Administration of influenza virus vaccine | Office | 29 | 27 | $32.75 | $950 |
| 93922 Duplex Scan - Extremity Arteries | Office | 24 | 24 | $54.20 | $1,301 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 23 | 20 | $68.88 | $1,584 |
By year: 2022 $69K for 826 services; 2023 $56K for 711 services; 2024 $44K for 534 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87428 Infectious Agent Detection by DNA/RNA | 23 | 20 | $68.88 | $1,584 |
Medicare prescription drug claims, 2024
In 2024, the drug Tram Ho prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,671 prescriptions and refills. In total Tram Ho wrote 23,777 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,671 | 7,880 | 828 | $7,968 |
| Amlodipine Besylate Generic | 1,452 | 4,230 | 457 | $2,022 |
| Losartan Potassium Generic | 1,425 | 4,210 | 444 | $4,477 |
| Metformin Hcl Generic | 1,112 | 3,306 | 358 | $2,103 |
| Famotidine Generic | 655 | 1,886 | 241 | $4,330 |
| Gabapentin Generic | 607 | 1,417 | 211 | $5,281 |
| Alendronate Sodium Generic | 463 | 1,300 | 162 | $1,315 |
| Ozempic Semaglutide | 460 | 543 | 86 | $482K |
| Donepezil Hcl Generic | 432 | 1,240 | 158 | $1,575 |
| Rosuvastatin Calcium Generic | 431 | 1,284 | 146 | $2,559 |
| Levocetirizine Dihydrochloride Generic | 383 | 915 | 151 | $1,054 |
| Fluticasone Propionate Generic | 356 | 647 | 131 | $2,583 |
| Carvedilol Generic | 345 | 998 | 123 | $1,409 |
| Levothyroxine Sodium Generic | 344 | 1,032 | 105 | $2,534 |
| Farxiga Dapagliflozin Propanediol | 322 | 576 | 94 | $324K |
Brand drugs: 3,452 claims; generic drugs: 20,113 claims; opioid claims: 241.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tram Ho $1,069 ($1,069 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $267.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 17 | $267 |
| Novo Nordisk Inc NVO | 7 | $136 |
| Genzyme Corporation SNY | 4 | $115 |
| Lilly USA, LLC LLY | 5 | $105 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $71.87 |
| Medtronic, Inc. MDT | 1 | $62.43 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $49.69 |
| GlaxoSmithKline, LLC. GSK | 3 | $48.78 |
| Gilead Sciences, Inc. GILD | 2 | $43.79 |
| Exact Sciences Corporation EXAS | 3 | $42.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.